Tabula Rasa HealthCare Rule of 40
Delisted
The Rule of 40 of Tabula Rasa HealthCare (TRHC) as of Aug 24, 2026 is -32.26 %. In the previous year, Rule of 40 was -9.47 % — a change of 240.50% (lower).
Get this data via API
Financial Data API
Rule of 40
-32.26 %
YoY
240.50%
Last updated:
Rule of 40 of Tabula Rasa HealthCare is 2026 -32.26 % . Rule of 40 of Tabula Rasa HealthCare was 2025 -9.47 % . It decreases by 240.50% lower compared to the previous year.
The Tabula Rasa HealthCare Rule of 40 history
3 Years
10 Years
25 Years
Max
Rule of 40
Date
Rule of 40
Jan 1, 2015
53.43 USD
Jan 1, 2016
39.14 USD
Jan 1, 2017
46.91 USD
Jan 1, 2018
51.69 USD
Jan 1, 2019
29.25 USD
Jan 1, 2020
-15.03 USD
Jan 1, 2021
-9.47 USD
Jan 1, 2022
-32.26 USD
| YEAR | Rule of 40 | YoY |
|---|---|---|
| -32.26 % | +240.50% | |
| -9.47 % | -36.98% | |
| -15.03 % | -151.39% | |
| 29.25 % | -43.41% | |
| 51.69 % | +10.20% | |
| 46.91 % | +19.85% | |
| 39.14 % | -26.75% | |
| 53.43 % | — |
Access this data via the Eulerpool API
Tabula Rasa HealthCare Stock analysis
What does Tabula Rasa HealthCare do? Tabula Rasa HealthCare Inc is a US-based company specializing in the development of innovative healthcare solutions. The company was founded in 2009 by CEO and Chairman Calvin H. Knowlton and is headquartered in Moorestown, New Jersey.
The business model of Tabula Rasa Healthcare offers a wide range of technology solutions focused on improving clinical processes and patient safety. These technology solutions are incorporated into its medication management programs and include electronic medication profiles and clinical decision support systems.
By adding SinfoniaRx, Tabula Rasa HealthCare is able to provide a holistic approach to improving medication adherence and compliance. The company offers a broad range of services to enable efficient monitoring of medication effects. Tabula Rasa HealthCare's technology enables personalized medication delivery to ensure that each patient receives the right medication at the right time.
Tabula Rasa HealthCare operates in three business divisions: medication safety, medication therapy management, and population health management.
In the field of medication safety, the company provides solutions that enable medical personnel to conduct a comprehensive assessment of a patient's medical history and create an accurate medication list. The company also offers support for risk assessment and medication management in patients with multiple or complex chronic conditions.
The medication therapy management division covers a range of individual measures aimed at monitoring medication therapies. Tabula Rasa HealthCare's solutions assist healthcare professionals in better understanding patients' medication and improving treatment outcomes.
In the population health management field, the company offers tools and strategies for optimizing communicative data analysis to minimize patient requirements and healthcare costs. The company provides technology solutions to revolutionize patient care through the integration of data analytics and a focus on preventive measures. This helps patients achieve better treatment outcomes, detect diseases at an early stage, and save costs.
In summary, Tabula Rasa HealthCare Inc is a company focused on developing technology solutions to improve medical decision-making and maximize patient safety. The company utilizes its expertise in various areas and provides customized solutions to ensure personalized and optimized medication delivery. Its business model includes a holistic approach to improving medication adherence and compliance. Tabula Rasa HealthCare is driving medical research and the development of technology solutions to revolutionize modern patient care. Tabula Rasa HealthCare is one of the most popular companies on Eulerpool.
Frequently Asked Questions about Tabula Rasa HealthCare stock
Rule of 40 of Tabula Rasa HealthCare is -32.26 % in 2026.
On Eulerpool you can find the complete historical development of Rule of 40 Tabula Rasa HealthCare since 2006 – with annual values, charts, and detailed analysis.
The Rule of 40 states that a company's revenue growth rate plus profit margin should exceed 40%. It is widely used to evaluate SaaS and high-growth companies.
Access this data via the Eulerpool API
Quality — Tabula Rasa HealthCare
All Key Metrics — Tabula Rasa HealthCare
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth